CDC studies of registry data (3, continued)
		l TB control activities targeting prompt identification of TB and completion of therapy will not reduce TB among the FB l Geographic variation of TB requires locally tailored approaches – Areas with recent (case identification) vs. remote arrivals (screen for LTBI) – Areas of high isonaizid resistance may require alternative LTBI treatment regimens